Skip to content
EN
DE
*protected email*
+49 211 942 522 98
Toggle Navigation
About us
Technology
Pipeline
Working with us
Partnering & Investing
Careers
Media
News & Events
Press
Press Release
Categories
Press Release
6
News
9
Event
3
News, Press Release
Priavoid receives funding from the Alzheimer’s Association and the Rainwater Charitable Foundation to further develop its tau program
Continue reading
News, Press Release
New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study
Continue reading
News, Press Release
Priavoid and Research Center Jülich receive funding from The Michael J. Fox Foundation
Continue reading
News, Press Release
Priavoid closes financing round
Continue reading
News, Press Release
Alzheimer´s Research: Important Milestone for PRI-002
Continue reading
News, Press Release
Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board
Continue reading
Page load link
